Figure 11
2D and 3D-interactions of compounds and targeted proteins. (A) EGFR/Clionasterol; (B) EGFR/Cycloeucalenol; (C) HER2/Cycloartenol; (D) HER2/Heptanediamide, N,Nʹ-di-benzoyloxy.
Figure 11 | Scientific Reports
2D and 3D-interactions of compounds and targeted proteins. (A) EGFR/Clionasterol; (B) EGFR/Cycloeucalenol; (C) HER2/Cycloartenol; (D) HER2/Heptanediamide, N,Nʹ-di-benzoyloxy.
